IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Keep in touch with IntegrChain through our news and frequent events.
View all news & events
January 14, 2014 | Brandon Underwood
Have you ever considered leaving your legacy – platform that is? This week at the ECRM Branded Pharmaceuticals event in Chicago, IL, our team will be talking a lot about the benefits of leaving behind your legacy platform and making the switch to informed applications. Many of our customers have made the switch from legacy platforms in order to manage their buyer/seller relationships more effectively and encourage proactive collaboration.
So, what does this exactly mean you may be asking yourself? Well, do you find yourself sitting at your desk frequently waving your fist in frustration at your computer because your current platform does not offer much flexibility, has limited and constrained functionality, or requires way to much manual effort to actually make sense of all the data you receive, let alone use it for empowered decision-making? Well, you’re not alone. Several of our customers found themselves in this exact position. Here are their stories of how they overcame the trials and tribulations of legacy platforms and how leaving their legacy changed the way they do business forever.
A leading global pharmaceutical manufacturer found themselves using several disparate systems to handle channel data management, distribution agreement scorecarding, and order management. These inefficient systems made using channel data for informed decision-making very difficult and the risk of error in agreements and order management were very high. After making the move to DNA, the manufacturer was not only able to move all of these processes into one collaborative system, they also were able to process more than $690 million in orders with zero errors, improve service level above 99%, realize an annual system and IT savings of $500,000, and essentially grow the business a full 1%.
To learn about the other success stories, download our Leaving the Legacy eBook here:
Please share your own experience with legacy platforms in the comments.
Tags: Channel Data Inefficencies, Channel Data Management, Distribution Agreement Scorecarding, DNA Customer Success, Informed Applications, Order Management, Proactive Collaboration, Sales Predictability
